Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.
Zhu D, Judge PK, Francis ST, Che Z, Rayner JJ, Buchanan C, Mayne KJ, Stevens W, Bley T, Bhandary N, Byrne C, Cejka V, Chapman D, Cox EF, Dasgupta T, Malijan GB, Nicholas R, Phelan P, Smith E, Tunnicliffe EM, Wooding N, Nangaku M, Cherney DZI, Selby NM, Taal M, Steubl D, Aoqui C, Wanner C, Emberson JR, Landray MJ, Baigent C, Staplin N, Herrington WG, Haynes R; EMPA-KIDNEY Collaborative Group.
Zhu D, et al.
Am J Kidney Dis. 2025 Dec 11:S0272-6386(25)01208-9. doi: 10.1053/j.ajkd.2025.09.022. Online ahead of print.
Am J Kidney Dis. 2025.
PMID: 41390143
No abstract available.